This CAST literature review and report looks at problems caused by the current system of asynchronous approvals for biotech crops. The authors focus on the economic effects in countries that are major global commodity exporters and importers, which show that asynchrony in the global approval of new biotech crops and the resultant risk of low level presence (LLP) puts large volumes of trade worth billions of dollars at risk.
Farmers already recognize that many consumers seek out specific food claims—natural, organic, non-GMO and farm-to-retailer marketing, among others. But three new values are expected to cross over into purchases of food, consumer products and more in the months ahead. Read moreRead More »